期刊文献+

重组鸡α干扰素/白细胞介素-2融合蛋白体外活性评价方法研究 被引量:4

Study on the Activity Estimation Methods of Recombinant Chicken Interferon-α/Interleukin-2 Fusion Protein in vitro
下载PDF
导出
摘要 为建立稳定、便捷的重组鸡α干扰素/白细胞介素-2融合蛋白(rChIFN-α-Linker-ChIL-2蛋白,重组融合蛋白)体外活性评价方法,本研究分别采用ChIFN-α和ChIL-2ELISA方法检测重组融合蛋白与抗ChIFN-α单抗和抗ChIL-2单抗发生特异性免疫反应的活性;采用细胞病变抑制法检测重组融合蛋白在DF1细胞上抑制水疱性口炎病毒(VSV)和传染性法氏囊病病毒(IBDV)增殖活性;采用MTS法分别测定重组融合蛋白促鸡外周血T淋巴细胞(PBLC)和脾淋巴细胞增殖活性。结果表明,重组融合蛋白可以与抗ChIFN-α单抗和抗ChIL-2单抗发生特异性免疫反应;重组融合蛋白在DF1细胞上具有明显抗病毒活性,其抗VSV活性高于抗IBDV活性,且均明显高于rChIFN-α蛋白对照;不同浓度的重组融合蛋白均具有明显的促鸡PBLC和脾淋巴细胞增殖活性,且其促增殖活性明显高于rChIFN-α蛋白对照。本研究成功建立了重组融合蛋白体外活性检测评价方法,为进一步探究重组融合蛋白在鸡体内协同作用奠定基础。 In order to establish a stable,simple and rapid detection method to estimate the activities of the recombinant chicken interferon-α/interleukin-2fusion protein(rChIFN-α-Linker-ChIL-2,recombinant fusion protein)in vitro,the activities of rChIFN-α-Linker-ChIL-2were estimated by detecting its specific immune response to monoclonal antibody(MAb)against ChIFN-αand ChIL-2by ELISA assay.The antiviral activities of rChIFN-α-Linker-ChIL-2protein were tested by inhibiting the 50% appearance of cytopathic effect(CPE)of vesicular stomatitis virus(VSV)and infectious bursal disease virus(IBDV)on the passage cell lines DF1.The promoting proliferation activities of lymphocytes in the chicken peripheral blood and spleen of recombinant fusion protein were tested by MTS method.The results showed that rChIFN-α-Linker-ChIL-2protein had the ability of specific immune response to anti-ChIFN-α MAb and anti-ChIL-2 MAb,respectively.The antiviral activity of rChIFN-α-Linker-ChIL-2protein inhibiting the reproduction of VSV on DF1 cell line was higher than IBDV,and both of the antiviral activities of recombinant fusion protein against VSV and IBDV were much higher than the recombinant ChIFN-αprotein(rChIFN-α)control.The recombinant fusion protein had apparent promoting proliferation activity of lymphocytes in the chicken peripheral blood and spleen,which were much higher than that of the rChIFN-αcontrol.The study suggested that the activities detection and estimation methods of the recombinant fusion protein in vitro were successfully established,which laid the foundation for the further study of the synergy activity of recombinant fusion protein in vivo.
出处 《中国畜牧兽医》 CAS 北大核心 2015年第12期3153-3159,共7页 China Animal Husbandry & Veterinary Medicine
基金 河南省科技创新人才计划项目(豫科人组[2011]1号)
关键词 鸡α干扰素 鸡白细胞介素-2 重组融合蛋白 体外活性 chicken interferon-α chicken interleukin-2 recombinant fusion protein in vitro activity
  • 相关文献

参考文献15

  • 1Meager A. Biological assays for interferons[J]. Jour nal of Immunological Methods, 2002, 261(1/2) : 21-36.
  • 2Johnson H M,Bazer F W,Szente B E,et al. How in- terferons fight disease[J]. Scientific American, 1994, 270(5) :68 75.
  • 3Sekellick M J, Ferrandino A F, Hopkins D A, et al. Chicken interferon gene: Cloning, expression, and analysis[J]. Journal of Interferon Research, 1994, 14:71-79.
  • 4程福亮,聂兆晶,陈甜甜,刘洋庆,房栋,崔兆连,谷巍,王春凤.重组鸡α-干扰素的表达及其生物活性的初步研究[J].中国畜牧兽医,2014,41(11):35-39. 被引量:5
  • 5刘成倩,王静,李红,于宗幸,易建中,陈磊.鸡干扰素-α基因原核表达载体的构建及高效表达[J].中国畜牧兽医,2014,41(4):47-50. 被引量:7
  • 6Liao W J, Lin X, Leonard W J. Interleukin-2 at the crossroads of effector responses, tolerance, and immu- notherapyFJ3. Immunity,2013,38(1) : 13-25.
  • 7Taguchi T. Interleukin-2 (IL-2)I-J3. Gan To Kagaku Ryoho, 1994,21 (5) . 719-724.
  • 8Robak T. Biological properties and therapeutic use of interleukin 2 (IL-2)[J]. Postepy Higieny Medycyny Doswiadczalnej, 1995,49(3) . 367-393.
  • 9Prentice H G, Macdonald I D, Hamon M D. The role of imrnunotherapy in the treatment of acute myelo- blastie leukemia:From allogeneic bone marrow trans- plantation to the application of interleukin 2[J]. Cancer Treatment and Research, 1993,64 : 121-134.
  • 10闫若潜,谢彩华,吴志明,张志凌,刘光辉,刘梅芬.鸡α干扰素/白细胞介素2基因的融合表达及活性研究[J].中国农业科学,2010,43(3):594-604. 被引量:16

二级参考文献66

  • 1刘会珍,吴薇,高振江.保鲜剂性质对鸡蛋保鲜效果的影响[J].中国农业大学学报,2005,10(5):89-92. 被引量:34
  • 2史耀旭,关贵全,高金亮,党志胜,刘志杰,刘爱红,马米玲,任巧云,罗建勋,殷宏,曾巧英.鸡γ-干扰素基因的克隆及原核表达[J].中国兽药杂志,2006,40(7):12-16. 被引量:6
  • 3童光志,周艳君,郝晓芳,田志军,仇华吉,彭金美,安同庆.高致病性猪繁殖与呼吸综合征病毒的分离鉴定及其分子流行病学分析[J].中国预防兽医学报,2007,29(5):323-327. 被引量:387
  • 4周海龙,韦双双,谢俊,郑继平,朱庆.家禽干扰素的研究进展[J].畜禽业,2007,18(7):16-18. 被引量:5
  • 5MEAGER A. Biological assays for interferons[J].Journal of Immunology Methods, 2002,261 (1-2) : 21-36.
  • 6JOHNSON H M, BAZER F W, SZENTE B E, et al. How interferons fight disease [J].Scientific American, 1994, 270(5) :68-75.
  • 7TOSSING G. Interferon-alpha in treatment of chronic hepatitis C in co-infected HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients [J].European Journal of Medicinal Research, 2002, 7(1): 44-46.
  • 8TAGUCHI T. Interleukin-2 (IL-2) [J]. Gan To Kagaku Ryoho, 1994, 21(5) :719-724.
  • 9ROBAK T. Biological properties and therapeutic use of interleukin 2 (IL-2)[J]. Advances in Hygiene and Experimental Medicine, 1995, 49(3) : 367-393.
  • 10PRENTICE H G, MACDONALD I D, HAMON M D. The role of immunotherapy in the treatment of acute myeloblastic leukemia: from allogeneic bone marrow transplantation to the application of interleukin 2[J]. Cancer Treatment Research, 1993,64 : 121-124.

共引文献33

同被引文献42

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部